RabAvert is a Kit in the Vaccine category. It is labeled and distributed by Glaxosmithkline Biologicals Sa. The primary component is .
Product ID | 58160-964_6aaf45e1-7af5-4d94-be4f-72eeadc2e0d9 |
NDC | 58160-964 |
Product Type | Vaccine |
Proprietary Name | RabAvert |
Generic Name | Rabies Vaccine |
Dosage Form | Kit |
Marketing Start Date | 2016-12-19 |
Marketing End Date | 2024-01-31 |
Marketing Category | BLA / BLA |
Application Number | BLA103334 |
Labeler Name | GlaxoSmithKline Biologicals SA |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Marketing Start Date | 2016-12-19 |
Marketing End Date | 2024-01-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103334 |
Product Type | VACCINE |
Billing Unit | EA |
Marketing Start Date | 2016-12-19 |
NDC | Brand Name | Generic Name |
---|---|---|
50090-1820 | RabAvert | Rabies Vaccine |
50090-3096 | RabAvert | Rabies Vaccine |
50632-010 | RabAvert | Rabies Vaccine |
58160-964 | RabAvert | Rabies Vaccine |
63851-501 | RabAvert | Rabies Vaccine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RABAVERT 79301264 not registered Live/Pending |
BAVARIAN NORDIC A/S 2020-10-16 |
RABAVERT 75172869 2200256 Live/Registered |
GSK VACCINES GMBH 1996-09-27 |